Archive | Alpert’s Editorials RSS feed for this section
Joseph S. Alpert

A Sticky Problem: Dealing with Industry Under Unpleasant Circumstances

  In this issue of the American Journal of Medicine, Dr Leonard Fromer appropriately calls for easier access to potential lifesaving therapy, the epinephrine auto injector, for patients with severe allergic reactions. The editor and the staff of the AJM strongly support the concept that epinephrine auto injectors should be made affordable and easily accessible for patients who are […]

Read more
Joseph S. Alpert

Reflections on a Recent Trip to Lithuania and the Global Family of Physicians

My wife and I recently returned from a trip to Vilnius, Lithuania. It was my third trip there and her second. Each time we have gone to Lithuania, we have been made to feel like members of our host’s family. Here is the story that led to our current close personal and professional friendships in […]

Read more

Genetically Informed Medicine

  As many readers will remember from an earlier editorial entitled “What’s in a Word? Using Words Carefully,”1 I pointed out the danger in using words without first carefully considering the implications of the written or spoken terms for individuals and for society. In this editorial, I described one of my patients who had mistakenly been […]

Read more

Nutraceuticals: Evidence of Benefit in Clinical Practice?

Nutraceuticals, according to Wikipedia, are food substances or nutritional supplements that have beneficial effects on health. They are not usually considered to be part of a normal diet, such as fruit, vegetable, fish, and meat. Rather, they are additives, usually derived from plants, which are said to be beneficial at preventing or treating illnesses. The term nutraceutical, […]

Read more
man holding chest and woman offering him water

To Supplement or Not: A Role for Antioxidant Vitamins in the Management of Heart Failure?

  There is an epidemic of heart failure occurring in advanced industrial nations. The number one diagnosis for payment by Medicare in the US is heart failure. Because heart failure is increasingly prevalent among the elderly, and because the population of individuals older than age 65 years is increasing rapidly in the US, patients with […]

Read more
UA-42320404-1